Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors (Q40388768)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors
scientific article

    Statements

    Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors (English)
    Masaki Miyazaki
    Ryotaroh Morinaga
    Yoshikazu Hasegawa
    Masaaki Terashima
    Masahiro Fukuoka
    Yutaka Ariyoshi
    Toshikazu Saito
    Noriyuki Masuda
    Hirokazu Watanabe
    Tetsuo Taguchi
    Yohko Hashimoto
    Kazuhiko Nakagawa

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit